Angiostrongylus cantonensis: apoptosis of inflammatory cells induced by treatment with mebendazole or/and interleukin 12 in mice

Exp Parasitol. 2007 Mar;115(3):226-32. doi: 10.1016/j.exppara.2006.09.004. Epub 2006 Oct 17.

Abstract

Angiostrongylus cantonensis is the major cause of human eosinophilic meningoencephalitis. ICR mice were infected orally with 35 infective larvae and sacrificed at 4-14 days, 25 days or 32 days post infection (dpi) for pathological and immunocytochemical examinations. In the non-treated group, no apoptosis signal was found in the meninges or parenchyma of the brains (4-14 dpi). Only a few apoptotic cells were noticed at 25 dpi (3%) and 32 dpi (10%). In the groups, the animals were given a single dose of mebendazole (20 mg/kg, per os at various times) or injections of interleukin 12 (IL-12) (10 ng/daily, intraperitoneally), all the animals were sacrificed at 14 dpi; the number of apoptotic cells was increased (17-21%). In the group that received a single dose of mebendazole (4 dpi) in combination with IL-12 injections (4-13 dpi), mild meningitis was observed, and most of the infiltrated inflammatory cells were in the apoptotic program (55%). Taken together, apoptosis of the inflammatory cells (most were eosinophils) could be induced when the infected mice were treated with mebendazole or/and IL-12.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adjuvants, Immunologic / pharmacology
  • Adjuvants, Immunologic / therapeutic use
  • Angiostrongylus cantonensis / drug effects*
  • Angiostrongylus cantonensis / physiology
  • Animals
  • Antinematodal Agents / pharmacology*
  • Antinematodal Agents / therapeutic use
  • Apoptosis / drug effects
  • Biomphalaria
  • Brain / drug effects
  • Brain / parasitology
  • Brain / pathology*
  • Caspase 3 / immunology
  • Drug Therapy, Combination
  • Eosinophilia / drug therapy
  • Eosinophilia / parasitology
  • Eosinophilia / pathology
  • Immunohistochemistry
  • In Situ Nick-End Labeling
  • Interleukin-12 / pharmacology*
  • Interleukin-12 / therapeutic use
  • Male
  • Mebendazole / pharmacology*
  • Mebendazole / therapeutic use
  • Meningitis / drug therapy
  • Meningitis / parasitology
  • Meningitis / pathology
  • Meningoencephalitis / drug therapy
  • Meningoencephalitis / parasitology
  • Meningoencephalitis / pathology
  • Mice
  • Mice, Inbred ICR
  • Proto-Oncogene Proteins c-akt / immunology
  • Rats
  • Rats, Wistar
  • Strongylida Infections / drug therapy*
  • Strongylida Infections / pathology

Substances

  • Adjuvants, Immunologic
  • Antinematodal Agents
  • Interleukin-12
  • Mebendazole
  • Proto-Oncogene Proteins c-akt
  • Caspase 3